Indus Biotech Limited, headquartered in India, is a prominent player in the biotechnology sector, specialising in advanced diagnostics and innovative healthcare solutions. Founded in 2005, the company has established itself as a leader in the development of cutting-edge molecular diagnostics, catering to both domestic and international markets. With a focus on precision medicine, Indus Biotech offers a range of unique products, including genetic testing and disease management solutions that stand out for their accuracy and reliability. The company has achieved significant milestones, including collaborations with leading research institutions, which have bolstered its market position. Recognised for its commitment to quality and innovation, Indus Biotech Limited continues to drive advancements in the biotechnology industry, making substantial contributions to healthcare and improving patient outcomes across various regions.
How does Indus Biotech Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Indus Biotech Limited's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Indus Biotech Limited, headquartered in India, currently does not have available carbon emissions data for recent years, as indicated by the absence of specific figures. Consequently, there are no reported emissions in terms of Scope 1, 2, or 3. Additionally, the company has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi) or similar climate pledges. In the context of the biotechnology industry, companies are increasingly recognising the importance of addressing climate change and reducing carbon footprints. While Indus Biotech Limited has not disclosed specific initiatives or targets, the industry as a whole is moving towards more sustainable practices and transparency in emissions reporting.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Indus Biotech Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.